search
Back to results

A 3-day Course for CFS/ME

Primary Purpose

Chronic Fatigue Syndrome, Myalgic Encephalomyelitis

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
A 3-day course
Waiting list
Sponsored by
Norwegian University of Science and Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Fatigue Syndrome focused on measuring Health education, Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME), RCT, 3-day Course, Physical function, Fatigue, Cognitive techniques, Behavioral activation

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • CFS/ME diagnosis based on the Canada Consensus Criteria.
  • At least 50% out of school/work.
  • Readiness to change (corresponding to the preparation phase in transtheoretical model)
  • Has given informed consent.

Exclusion Criteria:

  • Assessed by a General Practitioner (GP):
  • Underlying physical illness or mental disorder that may explain the symptoms.
  • Suicide risk/previous suicide attempts.
  • Pregnancy.
  • Bedridden and in need of continuous care.
  • Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.

Sites / Locations

  • Department of Psychology, NTNURecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

A 3-day course

Waiting list

Arm Description

The course consists of teaching in basic psychology, stress physiology and practice of a specific technique with self-instructions and visualization in a group setting by non-health personnel

Treatment as usual (TAU)

Outcomes

Primary Outcome Measures

Physical function
Measured through the Short Form Health Survey (SF-36), physical function, a scale that measures physical function with questions relating to ability to perform physical activity. The instrument contains 10 items with three options on each question. The score range is 0 -100, where 100 is equivalent to no disability.

Secondary Outcome Measures

Fatigue
Measured through the Chalder Fatigue Questionnaire, an instrument that measures fatigue severity, both on mental and physical fatigue in the last month. The instrument contains 11 items with four different response options in each question. The scale ranges from 0-33, where higher score indicates greater fatigue.
Pain on a daily basis
Measured through the Brief Pain Inventory, an instrument measuring pain and its allied aspects. The instrument contains 11 items with numeric rating from 0-10, where higher score indicates more severe pain.
Post-Exertional Malaise
Measured through A Brief Questionnaire to Assess Post-Exertional Malaise, an instrument that measures symptoms after activity. The instrument contains 10 items, with options ranging from 0-4, where a higher score indicates more severity.
Mental wellbeing
Measured trough the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), an instrument that measures mental wellbeing. The instrument contains 14 items, with 5 response categories, summed to provide a single score. Higher score indicates better wellbeing.
Overall improvement
Measured through the Patient Global Impression of Change (PGIC) with one single item that measures change in function, symptoms and quality of life. The instrument has seven possible options ranging from very much better to very much worse.
Sick leave
Register data from the Norwegian Labour and Welfare Administration (NAV) on sick leave, benefits, diagnoses from 12 months before the 3-day course and 24 months after the 3-day course.

Full Information

First Posted
February 4, 2022
Last Updated
March 24, 2023
Sponsor
Norwegian University of Science and Technology
Collaborators
University of Oslo, Haukeland University Hospital, University of Bristol, Lørenskog municipality, The Research Council of Norway
search

1. Study Identification

Unique Protocol Identification Number
NCT05236465
Brief Title
A 3-day Course for CFS/ME
Official Title
A 3-day Course for Adults With Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME): a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 21, 2022 (Actual)
Primary Completion Date
April 1, 2024 (Anticipated)
Study Completion Date
April 1, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
Collaborators
University of Oslo, Haukeland University Hospital, University of Bristol, Lørenskog municipality, The Research Council of Norway

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem. In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures. There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed. If the 3-day course shows promising effects, this could have positive consequences for patients, relatives and health personnel, but also financially for the society and the municipality.
Detailed Description
This is a randomized controlled trial (RCT) to investigate potential effects (positive and negative) of a 3-day course with follow-up for 100 adults with CFS/ME. The 3-day course used in this trial is named the Lightning Process (LP). The course is built on the LP manual (Parker, 2013) and includes stress theory, Positive Psychology and knowledge about regulating thoughts, feelings and behavior, and through that positively influencing physiology. Positive and negative effects of the course on symptoms, disability and quality of life will be investigated, and a long-term follow-up of work participation conducted. Any adverse events experienced during or after the 3-day course will be handled according to protocol.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Keywords
Health education, Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME), RCT, 3-day Course, Physical function, Fatigue, Cognitive techniques, Behavioral activation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial, in which participants are randomly allocated to either the intervention group or to the waiting list control group.
Masking
InvestigatorOutcomes Assessor
Masking Description
The intervention group vs. waiting list control group status will be known to the participants and the personnel delivering the 3-day course. However, the investigator and outcome assessor will be masked to the conditions.
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A 3-day course
Arm Type
Experimental
Arm Description
The course consists of teaching in basic psychology, stress physiology and practice of a specific technique with self-instructions and visualization in a group setting by non-health personnel
Arm Title
Waiting list
Arm Type
Active Comparator
Arm Description
Treatment as usual (TAU)
Intervention Type
Behavioral
Intervention Name(s)
A 3-day course
Intervention Description
The course is built on the LP manual (Parker, 2013) and includes stress theory, Positive Psychology and knowledge about regulating thoughts, feelings and behavior, and through that positively influencing physiology.
Intervention Type
Behavioral
Intervention Name(s)
Waiting list
Intervention Description
Treatment as usual (TAU) in the first 10 weeks. After 10 weeks: Behavioural: A 3-day course. The course is built on the LP manual (Parker, 2013) and includes stress theory, Positive Psychology and knowledge about regulating thoughts, feelings and behavior, and through that positively influencing physiology.
Primary Outcome Measure Information:
Title
Physical function
Description
Measured through the Short Form Health Survey (SF-36), physical function, a scale that measures physical function with questions relating to ability to perform physical activity. The instrument contains 10 items with three options on each question. The score range is 0 -100, where 100 is equivalent to no disability.
Time Frame
10 weeks after the 3-day course
Secondary Outcome Measure Information:
Title
Fatigue
Description
Measured through the Chalder Fatigue Questionnaire, an instrument that measures fatigue severity, both on mental and physical fatigue in the last month. The instrument contains 11 items with four different response options in each question. The scale ranges from 0-33, where higher score indicates greater fatigue.
Time Frame
6 months after the 3-day course
Title
Pain on a daily basis
Description
Measured through the Brief Pain Inventory, an instrument measuring pain and its allied aspects. The instrument contains 11 items with numeric rating from 0-10, where higher score indicates more severe pain.
Time Frame
6 months after the 3-day course
Title
Post-Exertional Malaise
Description
Measured through A Brief Questionnaire to Assess Post-Exertional Malaise, an instrument that measures symptoms after activity. The instrument contains 10 items, with options ranging from 0-4, where a higher score indicates more severity.
Time Frame
6 months after the 3-day course
Title
Mental wellbeing
Description
Measured trough the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), an instrument that measures mental wellbeing. The instrument contains 14 items, with 5 response categories, summed to provide a single score. Higher score indicates better wellbeing.
Time Frame
6 months after the 3-day course
Title
Overall improvement
Description
Measured through the Patient Global Impression of Change (PGIC) with one single item that measures change in function, symptoms and quality of life. The instrument has seven possible options ranging from very much better to very much worse.
Time Frame
6 months after the 3-day course
Title
Sick leave
Description
Register data from the Norwegian Labour and Welfare Administration (NAV) on sick leave, benefits, diagnoses from 12 months before the 3-day course and 24 months after the 3-day course.
Time Frame
24 months after the 3-day course

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: CFS/ME diagnosis based on the Canada Consensus Criteria. At least 50% out of school/work. Readiness to change (corresponding to the preparation phase in transtheoretical model) Has given informed consent. Exclusion Criteria: Assessed by a General Practitioner (GP): Underlying physical illness or mental disorder that may explain the symptoms. Suicide risk/previous suicide attempts. Pregnancy. Bedridden and in need of continuous care. Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Leif Edward Ottesen Kennair, PhD prof
Phone
+47 90557004
Email
kennair@ntnu.no
First Name & Middle Initial & Last Name or Official Title & Degree
Live Landmark
Phone
+47 91855303
Email
Livelan@stud.ntnu.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Leif Edward Ottesen Kennair, PhD prof
Organizational Affiliation
NTNU, Department of Psychology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Psychology, NTNU
City
Trondheim
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Leif Edward Ottesen Kennair, PhD prof
Email
kennair@ntnu.no

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The study protocol, along with the intervention protocol, will be published and publicly available. Registry data will not be shared as this is not allowed to share according to Norwegian law. However, Anonymized data can be shared with other researchers on reasonable request for use in specific research projects on CFS/ME after this study has been published. Due to privacy concerns, the complete data files will not be shared online.
IPD Sharing Time Frame
The study protocol and the intervention protocol will be publicly available upon study completion.
IPD Sharing Access Criteria
Anonymized data involving self-report data will be shared upon reasonable request from other researchers for use in specific research projects on CFS/ME when the main analyses are completed and published.

Learn more about this trial

A 3-day Course for CFS/ME

We'll reach out to this number within 24 hrs